Intraveno(IV) Iron Drugs Market Report

China Intraveno(IV) Iron Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Aug 26, 2023
  • PAGES：186
  • REPORT CODE：GMM1758475
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Iron supplements are available in two forms: oral and intravenous. Intravenous iron preparations are superior to oral supplements, as these lead to higher and faster increase in iron and Hb levels. Oral supplements have disadvantages such as GI adverse events, poor adherence, poor gastrointestinal absorption, and non-compliance.

    This report elaborates on the current development of the Intraveno(IV) Iron Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Galenica

    • Fresenius Medical Care

    • Pharmacosmos

    • Luitpold Pharmaceuticals

    • Sanofi

    • AMAG Pharmaceuticals

    • Vifor Pharma

    • American Regent

    • Allergan

    By Type:

    • Iron Sucrose

    • Low Molecular Weight Iron Dextran

    • Ferric Gluconate

    • Ferric Carboxyl Maltose

    By Application:

    • Ambulatory Surgical Centers

    • Diagnostic Centers

    • Hospitals

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Intraveno(IV) Iron Drugs Market Overview 2018-2029

    • 1.1 China Intraveno(IV) Iron Drugs Industry Development Overview

    • 1.2 China Intraveno(IV) Iron Drugs Industry Development History

    • 1.3 China Intraveno(IV) Iron Drugs Industry Market Size (2018-2029)

    • 1.4 China Intraveno(IV) Iron Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Intraveno(IV) Iron Drugs Production Volume, Production Value and Growth Rate of Iron Sucrose (2018-2029)

      • 1.4.2 China Intraveno(IV) Iron Drugs Production Volume, Production Value and Growth Rate of Low Molecular Weight Iron Dextran (2018-2029)

      • 1.4.3 China Intraveno(IV) Iron Drugs Production Volume, Production Value and Growth Rate of Ferric Gluconate (2018-2029)

      • 1.4.4 China Intraveno(IV) Iron Drugs Production Volume, Production Value and Growth Rate of Ferric Carboxyl Maltose (2018-2029)

    • 1.5 China Intraveno(IV) Iron Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Intraveno(IV) Iron Drugs Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Centers (2018-2029)

      • 1.5.2 China Intraveno(IV) Iron Drugs Sales Volume, Sales Value and Growth Rate of Diagnostic Centers (2018-2029)

      • 1.5.3 China Intraveno(IV) Iron Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • 1.6 China Intraveno(IV) Iron Drugs Market Analysis by Region

      • 1.6.1 North China Intraveno(IV) Iron Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Intraveno(IV) Iron Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Intraveno(IV) Iron Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Intraveno(IV) Iron Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Intraveno(IV) Iron Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Intraveno(IV) Iron Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Intraveno(IV) Iron Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Intraveno(IV) Iron Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Intraveno(IV) Iron Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Intraveno(IV) Iron Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Intraveno(IV) Iron Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Intraveno(IV) Iron Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Intraveno(IV) Iron Drugs Industry Development

    Chapter 3 Intraveno(IV) Iron DrugsIndustry Chain Analysis

    • 3.1 Intraveno(IV) Iron Drugs Industry Chain

    • 3.2 Intraveno(IV) Iron Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Intraveno(IV) Iron Drugs Market

    • 3.3 Intraveno(IV) Iron Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Intraveno(IV) Iron Drugs Market

    Chapter 4 China Intraveno(IV) Iron Drugs Market, by Type

    • 4.1 China Intraveno(IV) Iron Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Intraveno(IV) Iron Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Intraveno(IV) Iron Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Intraveno(IV) Iron Drugs Production Volume and Growth Rate of Iron Sucrose

      • 4.5.2 China Intraveno(IV) Iron Drugs Production Volume and Growth Rate of Low Molecular Weight Iron Dextran

      • 4.5.3 China Intraveno(IV) Iron Drugs Production Volume and Growth Rate of Ferric Gluconate

      • 4.5.4 China Intraveno(IV) Iron Drugs Production Volume and Growth Rate of Ferric Carboxyl Maltose

    Chapter 5 China Intraveno(IV) Iron Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Intraveno(IV) Iron Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Intraveno(IV) Iron Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Ambulatory Surgical Centers

      • 5.5.2 China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Diagnostic Centers

      • 5.5.3 China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Hospitals

    Chapter 6 China Intraveno(IV) Iron Drugs Market, by Region

    • 6.1 China Intraveno(IV) Iron Drugs Production Volume and Production Value, by Region

    • 6.2 China Intraveno(IV) Iron Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Intraveno(IV) Iron Drugs Market Analysis

    • 7.1 North China Intraveno(IV) Iron Drugs Market, by Type

    • 7.2 North China Intraveno(IV) Iron Drugs Market, by Application

    Chapter 8 Central China Intraveno(IV) Iron Drugs Market Analysis

    • 8.1 Central China Intraveno(IV) Iron Drugs Market, by Type

    • 8.2 Central China Intraveno(IV) Iron Drugs Market, by Application

    Chapter 9 South China Intraveno(IV) Iron Drugs Market Analysis

    • 9.1 South China Intraveno(IV) Iron Drugs Market, by Type

    • 9.2 South China Intraveno(IV) Iron Drugs Market, by Application

    Chapter 10 East China Intraveno(IV) Iron Drugs Market Analysis

    • 10.1 East China Intraveno(IV) Iron Drugs Market, by Type

    • 10.2 East China Intraveno(IV) Iron Drugs Market, by Application

    Chapter 11 Northeast China Intraveno(IV) Iron Drugs Market Analysis

    • 11.1 Northeast China Intraveno(IV) Iron Drugs Market, by Type

    • 11.2 Northeast China Intraveno(IV) Iron Drugs Market, by Application

    Chapter 12 Southwest China Intraveno(IV) Iron Drugs Market Analysis

    • 12.1 Southwest China Intraveno(IV) Iron Drugs Market, by Type

    • 12.2 Southwest China Intraveno(IV) Iron Drugs Market, by Application

    Chapter 13 Northwest China Intraveno(IV) Iron Drugs Market Analysis

    • 13.1 Northwest China Intraveno(IV) Iron Drugs Market, by Type

    • 13.2 Northwest China Intraveno(IV) Iron Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Galenica

        • 14.1.1 Galenica Company Profile

        • 14.1.2 Galenica Intraveno(IV) Iron Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Fresenius Medical Care

        • 14.2.1 Fresenius Medical Care Company Profile

        • 14.2.2 Fresenius Medical Care Intraveno(IV) Iron Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Pharmacosmos

        • 14.3.1 Pharmacosmos Company Profile

        • 14.3.2 Pharmacosmos Intraveno(IV) Iron Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Luitpold Pharmaceuticals

        • 14.4.1 Luitpold Pharmaceuticals Company Profile

        • 14.4.2 Luitpold Pharmaceuticals Intraveno(IV) Iron Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Sanofi

        • 14.5.1 Sanofi Company Profile

        • 14.5.2 Sanofi Intraveno(IV) Iron Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 AMAG Pharmaceuticals

        • 14.6.1 AMAG Pharmaceuticals Company Profile

        • 14.6.2 AMAG Pharmaceuticals Intraveno(IV) Iron Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Vifor Pharma

        • 14.7.1 Vifor Pharma Company Profile

        • 14.7.2 Vifor Pharma Intraveno(IV) Iron Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 American Regent

        • 14.8.1 American Regent Company Profile

        • 14.8.2 American Regent Intraveno(IV) Iron Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Allergan

        • 14.9.1 Allergan Company Profile

        • 14.9.2 Allergan Intraveno(IV) Iron Drugs Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Intraveno(IV) Iron Drugs Industry Research Conclusions

    • 15.2 Intraveno(IV) Iron Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Intraveno(IV) Iron Drugs Industry Market Size (2018-2029)

    • Figure China Intraveno(IV) Iron Drugs Production Volume, Production Value and Growth Rate of Iron Sucrose (2018-2029)

    • Figure China Intraveno(IV) Iron Drugs Production Volume, Production Value and Growth Rate of Low Molecular Weight Iron Dextran (2018-2029)

    • Figure China Intraveno(IV) Iron Drugs Production Volume, Production Value and Growth Rate of Ferric Gluconate (2018-2029)

    • Figure China Intraveno(IV) Iron Drugs Production Volume, Production Value and Growth Rate of Ferric Carboxyl Maltose (2018-2029)

    • Figure China Intraveno(IV) Iron Drugs Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Centers (2018-2029)

    • Figure China Intraveno(IV) Iron Drugs Sales Volume, Sales Value and Growth Rate of Diagnostic Centers (2018-2029)

    • Figure China Intraveno(IV) Iron Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure North China Intraveno(IV) Iron Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Intraveno(IV) Iron Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Intraveno(IV) Iron Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Intraveno(IV) Iron Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Intraveno(IV) Iron Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Intraveno(IV) Iron Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Intraveno(IV) Iron Drugs Market Size and Growth Rate from 2018-2029

    • Figure Intraveno(IV) Iron Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Intraveno(IV) Iron Drugs Market Share by Type in 2018

    • Figure China Intraveno(IV) Iron Drugs Market Share by Type in 2023

    • Figure China Intraveno(IV) Iron Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Intraveno(IV) Iron Drugs Production Volume and Growth Rate of Iron Sucrose (2018-2023)

    • Figure China Intraveno(IV) Iron Drugs Production Volume and Growth Rate of Low Molecular Weight Iron Dextran (2018-2023)

    • Figure China Intraveno(IV) Iron Drugs Production Volume and Growth Rate of Ferric Gluconate (2018-2023)

    • Figure China Intraveno(IV) Iron Drugs Production Volume and Growth Rate of Ferric Carboxyl Maltose (2018-2023)

    • Figure China Intraveno(IV) Iron Drugs Market Share by Application in 2018

    • Figure China Intraveno(IV) Iron Drugs Market Share by Application in 2023

    • Figure China Intraveno(IV) Iron Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Ambulatory Surgical Centers (2018-2023)

    • Figure China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Diagnostic Centers (2018-2023)

    • Figure China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Hospitals (2018-2023)

    • Table China Intraveno(IV) Iron Drugs Production Volume by Region (2018-2023)

    • Table China Intraveno(IV) Iron Drugs Production Volume Share by Region (2018-2023)

    • Figure China Intraveno(IV) Iron Drugs Production Volume Share by Region (2018-2023)

    • Table China Intraveno(IV) Iron Drugs Production Value by Region (2018-2023)

    • Table China Intraveno(IV) Iron Drugs Production Value Share by Region (2018-2023)

    • Figure China Intraveno(IV) Iron Drugs Production Value Share by Region (2018-2023)

    • Table China Intraveno(IV) Iron Drugs Sales Volume by Region (2018-2023)

    • Table China Intraveno(IV) Iron Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Intraveno(IV) Iron Drugs Sales Volume Share by Region (2018-2023)

    • Table China Intraveno(IV) Iron Drugs Sales Value by Region (2018-2023)

    • Table China Intraveno(IV) Iron Drugs Sales Value Share by Region (2018-2023)

    • Figure China Intraveno(IV) Iron Drugs Sales Value Share by Region (2018-2023)

    • Table North China Intraveno(IV) Iron Drugs Production Volume by Type (2018-2023)

    • Table North China Intraveno(IV) Iron Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Intraveno(IV) Iron Drugs Production Volume Share by Type (2018-2023)

    • Table North China Intraveno(IV) Iron Drugs Sales Volume by Application (2018-2023)

    • Table North China Intraveno(IV) Iron Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Intraveno(IV) Iron Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Intraveno(IV) Iron Drugs Production Volume by Type (2018-2023)

    • Table Central China Intraveno(IV) Iron Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Intraveno(IV) Iron Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Intraveno(IV) Iron Drugs Sales Volume by Application (2018-2023)

    • Table Central China Intraveno(IV) Iron Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Intraveno(IV) Iron Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Intraveno(IV) Iron Drugs Production Volume by Type (2018-2023)

    • Table South China Intraveno(IV) Iron Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Intraveno(IV) Iron Drugs Production Volume Share by Type (2018-2023)

    • Table South China Intraveno(IV) Iron Drugs Sales Volume by Application (2018-2023)

    • Table South China Intraveno(IV) Iron Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Intraveno(IV) Iron Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Intraveno(IV) Iron Drugs Production Volume by Type (2018-2023)

    • Table East China Intraveno(IV) Iron Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Intraveno(IV) Iron Drugs Production Volume Share by Type (2018-2023)

    • Table East China Intraveno(IV) Iron Drugs Sales Volume by Application (2018-2023)

    • Table East China Intraveno(IV) Iron Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Intraveno(IV) Iron Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Intraveno(IV) Iron Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Intraveno(IV) Iron Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Intraveno(IV) Iron Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Intraveno(IV) Iron Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Intraveno(IV) Iron Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Intraveno(IV) Iron Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Intraveno(IV) Iron Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Intraveno(IV) Iron Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Intraveno(IV) Iron Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Intraveno(IV) Iron Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Intraveno(IV) Iron Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Intraveno(IV) Iron Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Intraveno(IV) Iron Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Intraveno(IV) Iron Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Intraveno(IV) Iron Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Intraveno(IV) Iron Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Intraveno(IV) Iron Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Intraveno(IV) Iron Drugs Sales Volume Share by Application (2018-2023)

    • Table Galenica Company Profile

    • Table Galenica Intraveno(IV) Iron Drugs Revenue, Price and Gross (2018-2023)

    • Table Fresenius Medical Care Company Profile

    • Table Fresenius Medical Care Intraveno(IV) Iron Drugs Revenue, Price and Gross (2018-2023)

    • Table Pharmacosmos Company Profile

    • Table Pharmacosmos Intraveno(IV) Iron Drugs Revenue, Price and Gross (2018-2023)

    • Table Luitpold Pharmaceuticals Company Profile

    • Table Luitpold Pharmaceuticals Intraveno(IV) Iron Drugs Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Intraveno(IV) Iron Drugs Revenue, Price and Gross (2018-2023)

    • Table AMAG Pharmaceuticals Company Profile

    • Table AMAG Pharmaceuticals Intraveno(IV) Iron Drugs Revenue, Price and Gross (2018-2023)

    • Table Vifor Pharma Company Profile

    • Table Vifor Pharma Intraveno(IV) Iron Drugs Revenue, Price and Gross (2018-2023)

    • Table American Regent Company Profile

    • Table American Regent Intraveno(IV) Iron Drugs Revenue, Price and Gross (2018-2023)

    • Table Allergan Company Profile

    • Table Allergan Intraveno(IV) Iron Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US